The Global Recombinant Proteins Market is Predict to reach $2.6 Billion by 2028, at a CAGR of 10.8%

Published Date: 20-Jan-2023

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Recombinant Proteins Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Recombinant Proteins Market size is expected to reach $2.6 billion by 2028, rising at a market growth of 10.8% CAGR during the forecast period.

The Growth Factors & Chemokines segment acquired maximum revenue share in the Global Recombinant Proteins Market by Product in 2021 thereby, achieving a market value of $858.7 million by 2028. The growth factors and chemokines segment's significant contribution to research in areas like cancer, Covid-19, cell culture, neuroscience, stem cell research, transplantation, HIV/AIDS, and wound healing can be due to its substantial market share. Additionally, they assist in coordinating innate and adaptive immune responses. Interleukin-2 is one cytokine that is increasingly being employed as an adjuvant in the creation of vaccines.

The Pharmaceutical & Biopharmaceutical Companies segment has shown the growth rate of 10.1 % during (2022 - 2028). The market segment is anticipated to maintain its dominant position while growing at the quickest CAGR throughout the forecast period. The bio-manufacturers have invested millions of dollars in R&D to expand their product pipeline, develop new technologies, and improve bioprocessing tools as a result of the trend toward biologics and biosimilars.

The Drug Discovery & Development segment is generating highest revenue share in the Global Recombinant Proteins Market by Application in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $916.8 million by 2028. Recombinant proteins help in the discovery and development of new substances that affect how disease-associated proteins operate or the corresponding protein-protein interactions. Recombinant proteins have also developed into a crucial tool in the drug discovery process since they make it possible to quantify, localise, and modulate proteins of interest.

The North America market dominated the Global Recombinant Proteins Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $982.4 million by 2028. The Europe market is exhibiting a CAGR of 10.4% during (2022 - 2028). Additionally, The Asia Pacific market would display a CAGR of 11.4% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/recombinant-proteins-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Bio-Techne Corporation, Thermo Fisher Scientific, Inc., Merck Group, Bio-Rad Laboratories, Inc., Abcam plc, Genscript Biotech Corporation, Miltenyi Biotec B.V. & Co. KG, Proteintech Group, Inc., BPS Bioscience, Inc., and RayBiotech Life, Inc.

Global Recombinant Proteins Market Segmentation

By Product

  • Growth Factors & Chemokines
  • Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors
  • Structural Proteins
  • Membrane Proteins
  • Kinase Proteins & Regulatory Proteins
  • Immune Response Proteins
  • Others

By End User

  • Pharmaceutical & Biopharmaceutical Companies
  • Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations
  • Others

By Application

  • Drug Discovery & Development
  • Academic Research Studies
  • Biopharmaceutical Production
  • Diagnostics
  • Biotechnology Research
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Bio-Techne Corporation
  • Thermo Fisher Scientific, Inc.
  • Merck Group
  • Bio-Rad Laboratories, Inc.
  • Abcam plc
  • Genscript Biotech Corporation
  • Miltenyi Biotec B.V. & Co. KG
  • Proteintech Group, Inc.
  • BPS Bioscience, Inc.
  • RayBiotech Life, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Recombinant Proteins Market Future Scope & Opportunities 2022-2028

Europe Recombinant Proteins Market Size & Growth Forecast 2022-2028

Asia Pacific Recombinant Proteins Market Size, Share & Industry Outlook to 2028

LAMEA Recombinant Proteins Market Growth, Trends & Forecasts 2022-2028

Request a Free Sample Copy


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.